Nicolas Poirier

Chief Executive Officer at OSE IMMUNOTHERAPEUTICS

Net worth: 1 M $ as of 2024-03-30

42 year

Consumer Services

Health Technology

Nicolas Poirier active positions

Companies	Position	Start	End
OSE IMMUNOTHERAPEUTICS	Director/Board Member	2019-06-25	-
	Chief Executive Officer	2022-10-06	-
	Chief Tech/Sci/R&D Officer	2016-05-30	2022-10-06

Companies	Position	Start	End
Effimune SA Effimune SA BiotechnologyHealth Technology Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France.	Corporate Officer/Principal	2011-12-31	-

University of Nantes	Graduate Degree
Centre d'Etudes Supérieures de Techniques Industrielles	Undergraduate Degree
Louis Pasteur University	Graduate Degree

International

France

Operational

Sectoral

Consumer Services	4
Health Technology	3

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
OSE IMMUNOTHERAPEUTICS	Health Technology

Private companies	1
Effimune SA Effimune SA BiotechnologyHealth Technology Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France.	Health Technology

Private companies

Health Technology